
traZODone Hydrochloride Tablets, USP, 50 mg
Teva recalls traZODone HCl 50 mg tablets due to foreign tablets/capsules in product.
Do not take the recalled tablets. Return the product to the place of purchase or contact Teva Pharmaceuticals for a refund or replacement.
Recall at a glance
- Quantity recalled
- 175,392 bottles
Why it was recalled
Teva Pharmaceuticals is recalling traZODone Hydrochloride Tablets, USP, 50 mg, due to the presence of foreign tablets or capsules in the product. The affected product is a prescription antidepressant dispensed in 100-tablet bottles.
Is mine affected?
Check the NDC or UPC and strength printed on the package. Yours is affected if it matches one below.
traZODone Hydrochloride Tablets, USP
- Lot code
- 1394026, 2028
- Strength
- 50 mg
- NDC / UPC
- NDC 50111-560-01
Timeline
- Firm initiated recall
- Publicly announced
- Listed on Recall Canary
- Summary updated
Official source
Other Foreign Material recalls
Other recent recalls from Teva Pharmaceuticals USA, Inc
Editorial summary by Recall Canary · summary updated 2026-09-09 · primary source: U.S. Food and Drug Administration · severity reflects the agency's published classification
